EP3137078
Meðferð við sýkingu af völdum Delta-lifrarbólguveiru
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
1.5.2015EP published:
20.3.2019EP application number:
15785846.5
EP translation filed:
29.5.2019Grant published:
15.6.2019EPO information:
European Patent Register
Max expiry date:
30.4.2035Expiry date:
30.4.2025
Title:
TREATMENT OF HEPATITIS DELTA VIRUS INFECTION
Timeline
Today
1.5.2015EP application
20.3.2019EP Publication
29.5.2019Translation submitted
15.6.2019Registration published
30.4.2025Expires
Owner
Name:
EIT Pharma, Inc.Address:
11620 Wilshire Boulevard, Suite 350, CA 90025, Los Angeles, US
Inventor
Name:
CORY, DavidAddress:
Palo Alto, CA, US
Name:
CHOONG, IngridAddress:
Palo Alto, CA, US
Name:
GLENN, Jeffrey, S.Address:
Palo Alto, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461987315 PDate:
1.5.2014Country:
US
Number:
201462044766 PDate:
2.9.2014Country:
US
Number:
201462073413 PDate:
31.10.2014Country:
US
Number:
201562151349 PDate:
22.4.2015Country:
US
Classification
Categories:
A61K 31/4545, A61K 31/427, A61K 31/4178, A61K 31/46, A61K 31/451, A61P 31/12, A61K 45/06, A61K 31/426
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 21.5.2019
Expires: 30.4.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 6
Paid: 7.4.2020
Expires: 30.4.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 8.4.2021
Expires: 30.4.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 5.4.2022
Expires: 30.4.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 12.4.2023
Expires: 30.4.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.4.2024
Expires: 30.4.2025
Payer: Árnason Faktor ehf.